Screener
Kestra Medical Technologies KMTS Payments For Repurchase Of Initial Public Offering
Payments For Repurchase Of Initial Public Offering at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfInitialPublicOffering.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Proceeds from issuance of common stock | 149,291 | 215,789 |
| Proceeds from issuance of stock to non-controlling interest | — | 17,100 |
| Proceeds from capital contributions | — | 2,374 |
| Payment of IPO offering costs | — | (3,523) |
| Payment of equity issuance costs | (2,466) | (3,224) |
| Deemed dividend for payments to third party on behalf of shareholder | (323) | (1,654) |
| Proceeds from stock option exercises | 593 | - |
| Net cash provided by financing activities | 147,095 | 330,262 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's payments for repurchase of initial public offering?
- Kestra Medical Technologies (KMTS) reported payments for repurchase of initial public offering of $880.75K in Q1 2025.
- What does payments for repurchase of initial public offering mean?
- Reflects cash outflows associated with the buyback or settlement of shares related to the initial public offering process. This may include adjustments for over-allotments or specific contractual obligations triggered by the IPO. It provides insight into the net cash impact of the company's transition to public markets.
Ask your AI about Kestra Medical Technologies's payments for repurchase of initial public offering.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude